Equifax Inc.
NYSE:EFXConsulting Services
-$0.93 today
- Market cap
- $21.02B
- Beta
- 1.31
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.82
- Dividend yield
- 1.38%
Volume 1.13M
Average 1.76M
EFX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Equifax Inc.NYSE: EFX
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How EFX compares with its peers on the latest reported figures
- EFX's LTM Sep 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for EFX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Aug 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding EFX) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for EFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.92B | 5.12B | 5.27B | 5.68B | 6.07B |
| Cost of Revenue | 1.98B | 2.18B | 2.34B | 2.52B | 2.65B |
| Gross Profit | 2.94B | 2.95B | 2.93B | 3.16B | 3.43B |
| Gross Margin | 59.8% | 57.5% | 55.7% | 55.7% | 56.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.32B | 1.33B | 1.39B | 1.45B | 1.61B |
| Operating Expenses | 1.81B | 1.89B | 2B | 2.12B | 2.33B |
| Depreciation & Amortization | 489.6M | 568.6M | 619.8M | 680.6M | 726.9M |
| EBITDA | 1.58B | 1.68B | 1.58B | 1.72B | 1.87B |
| EBITDA Margin | 32.2% | 32.8% | 30.0% | 30.3% | 30.8% |
| Operating Income | 1.14B | 1.06B | 933.6M | 1.04B | 1.1B |
| Operating Margin | 23.1% | 20.6% | 17.7% | 18.3% | 18.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 145.6M | 183M | 241.4M | 229.1M | 212.3M |
| Other Income / Expenses | (188.8M) | (126.3M) | (215.7M) | (231.6M) | (200.3M) |
| Income Before Tax | 949.2M | 929.7M | 717.9M | 810.5M | 894.9M |
| Pre-Tax Margin | 19.3% | 18.2% | 13.6% | 14.3% | 14.7% |
| Income Tax Expense | 200.7M | 229.5M | 166.2M | 203.2M | 230.6M |
| Net Income | 744.2M | 696.2M | 545.3M | 604.1M | 660.3M |
| Net Margin | 15.1% | 13.6% | 10.4% | 10.6% | 10.9% |
| EPS (Basic) | 6.11 | 5.69 | 4.44 | 4.88 | 5.36 |
| EPS (Diluted) | 6.02 | 5.65 | 4.40 | 4.84 | 5.32 |
| Weighted Avg Shares | 121.9M | 122.4M | 122.9M | 123.8M | 123.2M |
| Weighted Avg Shares (Diluted) | 123.6M | 123.3M | 123.9M | 124.9M | 124.1M |
Equifax Inc.
NYSE:EFX
Intrinsic Alpha fair value
Locked
Current Price
$179.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.